Asked by: Jayne Kirkham (Labour (Co-op) - Truro and Falmouth)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many women have been affected by faulty PIP breast implants in Truro and Falmouth constituency.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Breast and Cosmetic Implant Registry (BCIR), set up in 2016, collects all implant data, and explant data where possible.
Practically, it is always difficult and often impossible to identify a model and product code on an explant. If explanted devices, or patients undergoing explant, cannot be linked to data collected at time of implant, then this often reduces explant data to 'patient, surgeon, location, date'. This in turn makes it impossible to monitor trends in explant/failure.
NHS England is in the process of clarifying and mandating the detail required in the BCIR and other device-related collections. This will place a greater responsibility on trusts to either identify a device at the point of explant, or to identify the device from internal trust records created during the same patient's implant procedure.
This will only be possible if the implant and explant are performed at the same trust. It is then the intention of NHS England to provide the same matching service for implant/explant where the trusts differ.
This solution will, when implemented, give a full, proactive picture of device longevity/risk, for the purposes of research and surveillance, alongside the existing ability to identify patients affected by a device recall notice.
Alongside this work, as part of the its reforms to the Medical Devices Regulations 2002, the Medicines and Healthcare products Regulatory Agency (MHRA) has introduced updated requirements for the post-market surveillance of medical devices, including implants, enabling both the manufacturer and the MHRA to identify issues with medical devices more easily and where necessary, for the MHRA to take fast action to safeguard public health.
Later this year, the MHRA intends to introduce a requirement for clinicians to provide patients with an implant card and information regarding any warnings, precautions, or measures to be taken by the patient or healthcare professional. This will strengthen transparency and support patients in understanding their implants.
Asked by: Jayne Kirkham (Labour (Co-op) - Truro and Falmouth)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, when the Joint Committee on Vaccination and Immunisation will next consider the potential merits of offering the Meningitis B vaccine to teenagers on the NHS.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Joint Committee on Vaccination and Immunisation (JCVI) meningococcal sub-committee have met several times over 2024 and 2025 to discuss the meningococcal vaccination programme. In June 2025, the sub-committee noted that when available, they would like to review a model evaluating the impact of the Meningitis B (MenB) vaccination when given in a teenage programme in a two-dose schedule, including impact on meningococcal disease and gonorrhoea.
In 2013, the JCVI advised that the cost-effectiveness of an adolescent MenB vaccination programme would be dependent on the impact of the vaccine on protection against meningococcal carriage, which was uncertain at the time. Since this advice was published, the JCVI has continued to review the MenB vaccination programme. Recent evidence, discussed by the JCVI meningococcal sub-committee in March 2025, indicated that MenB vaccination in adolescents has little to no effect on meningococcal carriage.
Asked by: Jayne Kirkham (Labour (Co-op) - Truro and Falmouth)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help prevent teenagers and young adults from contracting Meningitis B.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
Meningococcal disease is rare, and the incidence has declined over the last two decades following the introduction of vaccines targeting meningococcal disease including the MenACWY teenage vaccination programme.
There is no current Meningitis B (MenB) vaccination programme for teenagers and young adults.
The importance of raising awareness in parents, teenagers and other adults about the signs and symptoms of meningitis and septicaemia remains key. There are a range of resources developed by the UK Health Security Agency (UKHSA), co-branded with the National Health Service, that set out these key messages and their importance, such as the teenage guide to immunisation. The guide is available at the following link:
https://www.gov.uk/government/publications/immunisations-for-young-people
The UKHSA collaboratively produces a university vaccine communications toolkit. This is shared with the distribution lists of Universities UK and the Association of Managers of Student Services in Higher Education (AMOSSHE), and is available at the following link:
In addition, United Kingdom guidance on the public health management of meningococcal disease provides clear advice on the management of confirmed and probable cases of invasive meningococcal disease, including MenB, to minimise onward transmission and further associated cases. This guidance is available at the following link:
Asked by: Jayne Kirkham (Labour (Co-op) - Truro and Falmouth)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps are being taken to encourage the use of a surgical robot in Cornwall, in the context of it being the only region in England and Wales without one.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
Our 10-Year Health Plan commits to expanding surgical robot adoption over the next decade. We recognise the importance of ensuring equitable access and we will establish national registries for robotic surgery data from 2029 and develop telesurgery networks to support geographical equity of access to robotic assisted surgery.
Decisions on the procurement of robotic‑assisted surgery are made locally by NHS trusts and integrated care boards, in line with local need and national guidance. The Royal Cornwall Hospitals NHS Trust (RCHT) has a robotic surgery programme as a commitment in their refreshed 10-year strategy, which was approved at the RCHT Board on 8 January 2026.
Asked by: Jayne Kirkham (Labour (Co-op) - Truro and Falmouth)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, when guidance on clinical delegation will be published.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The regulators of registered healthcare professionals, including the General Medical Council (GMC) and the Nursing and Midwifery Council (NMC), are independent of the Government, are directly accountable to Parliament, and are responsible for operational matters concerning the discharge of their statutory duties. The United Kingdom’s model of healthcare professional regulation is founded on the principle of regulators operating independently from the Government.
The GMC has published the guidance ‘Delegation and referral’ while the NMC has published its guidance ‘Delegation and accountability’. Both regulators expect their registrants to follow the appropriate guidance when delegating clinical work.
Asked by: Jayne Kirkham (Labour (Co-op) - Truro and Falmouth)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many of the 10,910 additional urgent dental appointments allocated to Cornwall and the Isles of Scilly Integrated Care Board have been delivered since April 2025.
Answered by Stephen Kinnock - Minister of State (Department of Health and Social Care)
We have asked the integrated care boards (ICBs) to commission extra urgent dental appointments to make sure that patients with urgent dental needs can get the treatment they require. ICBs have been making extra appointments available from April 2025.
Appointments are available across the country, with specific expectations for each region. These appointments are more heavily weighted towards those areas where they are needed the most.
Data on delivery of urgent dental care, including additional delivery, will be published annually as part of the NHS Dental Statistics England Official Statistics series. These statistics are released each August and are the primary source of data on the delivery of NHS dental care.
Asked by: Jayne Kirkham (Labour (Co-op) - Truro and Falmouth)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support Royal Cornwall Hospitals NHS Trust in addressing the long waits for ambulances and emergency care at the acute hospital in Cornwall.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
We are committed to improving urgent and emergency care and returning to the waiting time standards set out in the National Health Service constitution through actions set out in Urgent and Emergency Care Plan for 2025/26 and the Medium Term Planning Framework for 2026/27 to 2028/29.
On the 6 June 2025, we published our Urgent and Emergency Care Plan for 2025/26, backed by a total of nearly £450 million of funding. The plan focuses on improvements that will see the biggest impact on urgent and emergency care performance next winter and on making urgent and emergency care better every day, including reducing ambulance handovers to a maximum of 45 minutes and actions to support at least 78% of patients in accident and emergency being seen within four hours.
The Royal Cornwall Hospitals NHS Trust has been focusing on its ‘clinical vision of flow’, alongside whole system work which is delivering improvement in urgent and emergency care performance.
Asked by: Jayne Kirkham (Labour (Co-op) - Truro and Falmouth)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential merits of deploying specialist endometriosis nurses in GP surgeries.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Government is committed to improving the diagnosis, treatment, and ongoing care for gynaecological conditions including endometriosis.
As self-employed contractors to the National Health Service, it is for general practices to determine how they run their operations, including decisions regarding nursing staff.
The Department, through the National Institute for Health and Care Research, has also commissioned a number of studies focused on endometriosis diagnosis, treatment, and patient experience.
Asked by: Jayne Kirkham (Labour (Co-op) - Truro and Falmouth)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential merits of a public awareness campaign on endometriosis.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Government recognises the challenges faced by women with endometriosis and the impact it has on their lives, their relationships, and their participation in education and the workforce.
In November 2024, the National Institute for Health and Care Excellence updated their guideline on endometriosis, to make firmer recommendations to healthcare professionals on the referral and investigation for women with a suspected diagnosis, in order to help the estimated one in 10 women with endometriosis receive a diagnosis faster. Alongside the updated guidelines, new treatments have been approved, and we are investing £5.6 million into research and taking action to cut gynaecology waiting lists through our Elective Reform Plan.
On 15 July, the Department for Education published the revised relationships education, relationships and sex education, and health education statutory guidance. This revised guidance emphasises the importance of ensuring that pupils have a comprehensive understanding of women’s health topics, including endometriosis.
We know that women deserve better, which is why we are renewing the Women’s Health Strategy, to assess the progress that has been made so far and to continue progressing delivery while empowering women with information about heavy menstrual bleeding and reproductive health conditions.
The 2022 Women’s Health Strategy identified many important issues which remain valid, so we now need to align the strategy with the 10-Year Health Plan and identify areas where we need to go further.
Asked by: Jayne Kirkham (Labour (Co-op) - Truro and Falmouth)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what (a) physical, (b) mental and (c) financial support is available to people diagnosed with endometriosis.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Government recognises the challenges faced by women with endometriosis and the impact it has on their lives.
The National Institute for Health and Care Excellence’s (NICE) guideline on endometriosis diagnosis and management recognises that endometriosis can be a long-term condition, and can have a significant physical, sexual, psychological, and social impact. On 11 November 2024, NICE published its updated version of this guideline, making firmer recommendations on referral and investigations which will help women receive a diagnosis and effective treatment faster.
Research has led to new treatments being made available for endometriosis, including the NICE approval of two pills to treat endometriosis this year, namely Relugolix and Linzagolix.
Individuals, including those diagnosed with endometriosis, can self-refer to NHS Talking Therapies or their general practitioner can refer them. NHS Talking Therapies offer evidence-based psychological therapies to help with common mental health problems.
Many integrated care boards are taking an innovative approach to endometriosis care. For example, in the North East and West of England there is the endometriosis transformation programme. This programme is addressing long waits for patients with severe endometriosis and improving patient pathways, from presentation in general practice through to management in secondary care.